Anguk Sitaforumin Tablet 50/500 mg
Sitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
MFDS item code 201505818 · Approved 2015.08.20
This product's status changed to Expired on 2025.08.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood sugar control in type 2 diabetes
This medication helps in the blood sugar control of patients with type 2 diabetes by using sitagliptin and metformin together. Taking it alongside dietary and exercise therapy can effectively manage blood sugar levels, thereby improving blood sugar levels and assisting diabetes treatment.
This medication is generally taken 2 times a day with meals. The dosage should be gradually increased to reduce gastrointestinal side effects caused by metformin. 1. Patients not receiving treatment with metformin: - The initial dosage is this medication 50/500 mg, 1 tablet taken twice daily, and it can be increased to 50/1000 mg, 1 tablet taken twice daily. 2. Patients receiving treatment with metformin: -
This medication contains two ingredients: sitagliptin and metformin, which are used in the treatment of diabetes. First, sitagliptin can cause serious allergic reactions in some patients. Such reactions may include anaphylaxis, angioedema, and serious skin rashes, so if any abnormal symptoms occur within 3 months of taking the medication, you should stop taking it immediately and consult a doctor. Additionally, sitagliptin can cause acute pancreatitis, which is inflammation of the pancreas, so if you experience symptoms such as abdominal pain, nausea, or vomiting, you should notify medical staff immediately. Metformin can cause a rare but very dangerous metabolic disorder known as lactic acidosis. This condition may be accompanied by symptoms such as muscle pain, fatigue, difficulty breathing, and abdominal pain, and if such symptoms occur, you should stop taking the medication immediately and visit a hospital. This medication should not be administered to patients with severely impaired kidney function, severe infections or dehydration, acute myocardial infarction, or other specific conditions. Furthermore, the medication should be discontinued for a certain period before and after tests involving radiocontrast agents, and it is also advisable for patients with liver dysfunction or for those who are pregnant or breastfeeding to avoid using this medication. During the medication period, blood sugar control should be checked periodically, and kidney function and vitamin B12 levels should also be tested regularly. This is especially crucial for elderly patients or those with weak kidney function. This medication can induce hypoglycemia, so caution is needed regarding hypoglycemic symptoms when meals are skipped or irregular, or when taken alongside other blood glucose-lowering agents. Symptoms of hypoglycemia may include dizziness, headache, tremors, and cold sweat. Moreover, excessive alcohol intake should be avoided during the use of this medication, and caution should also be taken in cases of intense exercise or poor nutritional status, as this can increase the risk of hypoglycemia or lactic acidosis. If you are undergoing surgery, you should stop taking the medication 48 hours prior to the surgery, and after confirming that kidney function has returned to normal post-surgery, you may restart the medication. Finally, if symptoms such as skin blisters or severe joint pain occur during the use of this medication, you should immediately inform your doctor and discontinue the medication.
Hives, severe hypersensitivity reactions (including anaphylaxis, angioedema, Stevens-Johnson syndrome involving exfoliative skin disease), acute pancreatitis (including fatal/non-fatal hemorrhagic or necrotizing pancreatitis), severe lactic acidosis, hypoglycemia (including severe hypoglycemia), difficulty breathing, acute renal failure, angioedema, severe swelling, acute renal failure, difficulty breathing, severe and disability-associated joint pain, vesicular erythema multiforme, severe swelling (peripheral edema)
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering, and it should be kept at a temperature between 1 degree and 30 degrees Celsius at room temperature. This will help maintain the medication's effectiveness and prevent degradation.
Pink oval film-coated tablet
Company packaging unit
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jongkun Dang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication · Combination
Jong Kun Dang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication · Combination
JongKeunDang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Sitagliptin Phosphate 62.04mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.